Robert L. Fine

First‐line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas

Jonathan Strosberg, Robert L. Fine, Junsung Choi et al. · Cancer · 2010 · 758 citations · Full text

Safety and Survival With GVAX Pancreas Prime and <i>Listeria Monocytogenes</i>–Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer

Dung T. Le, Andrea Wang‐Gillam, Vincent J. Picozzi et al. · Journal of Clinical Oncology · 2015 · 588 citations · Full text

Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience

Robert L. Fine, Anthony P. Gulati, Benjamin A. Krantz et al. · Cancer Chemotherapy and Pharmacology · 2013 · 251 citations

Columbia University Experience, Pancreatic Cancer, Medicine +8

Phorbol esters induce multidrug resistance in human breast cancer cells.

Robert L. Fine, Jitendra Patel, Bruce A. Chabner · Proceedings of the National Academy of Sciences · 1988 · 241 citations · Full text

Breast Oncology, Drug Target, Protein Kinase C +13

High-Dose Oral Tamoxifen, a Potential Multidrug-Resistance-Reversal Agent: Phase I Trial in Combination With Vinblastine

D L Trump, David C. Smith, Peter Ellis et al. · JNCI Journal of the National Cancer Institute · 1992 · 210 citations